Market Tracker

10/21 9:37am ET

Synageva BioPharma Corp (NASDAQ:GEVA)

74.10
Data as of Oct 20
 0.00 / 0.00%
Today’s Change
44.54
Today|||52-Week Range
119.42
+14.49%
Year-to-Date

Today’s Trading

Previous close74.10
Today’s openn.a.
Day’s range-- - --
Volume8,045
Average volume (3 months)264,601
Market cap$2.5B
Dividend yield--
Data as of 10/20/2014

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-81.14%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratioNM
Price/Sales135.92
Price/Book5.30

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp0.000.00%
OPHTOphthotech Corp0.000.00%
KITEKite Pharma Inc+1.86+5.42%
NVAXNovavax Inc-0.02-0.40%
Data as of 9:37am ET, 10/21/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)-$1.65
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts